Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif

被引:30
|
作者
Romani, Bizhan [1 ]
Engelbrecht, Susan [1 ]
Glashoff, Richard H. [1 ]
机构
[1] Univ Stellenbosch, Div Med Virol, Dept Pathol, ZA-7505 Tygerberg, South Africa
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; E3 UBIQUITIN LIGASE; CYTIDINE DEAMINASE APOBEC3G; CELL-CYCLE ARREST; ACCESSORY PROTEINS; VIRAL-RNA; SOCS-BOX; ENDOGENOUS RETROVIRUSES; ANTIRETROVIRAL ACTIVITY; REVERSE TRANSCRIPTION;
D O I
10.1007/s00705-009-0481-y
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like (APOBEC) proteins are members of a protein family sharing the common characteristic of cytidine deaminase activity. The antiviral activity of APOBEC3G and APOBEC3F has been studied more extensively than that of the other members of this family. The antiviral activity of APOBEC3B and APOBEC3DE has also been described. Studies of other APOBEC proteins have not revealed any antiviral activities against HIV-1; however, further investigation is required. In the absence of human immunodeficiency virus type 1 (HIV-1) virion infectivity factor (Vif), APOBEC3G and APOBEC3F are incorporated into HIV-1 virions and hypermutate the viral genomic DNA by their cytidine deaminase activity. HIV-1 Vif protein suppresses the antiviral role of APOBEC proteins by several mechanisms that lead to inhibition of incorporation of APOBEC3G/3F into HIV-1 virions. The detailed mechanisms involved in the suppression of APOBEC proteins by Vif are still being elucidated. Novel studies in which as yet undefined aspects of the suppression of APOBEC proteins are investigated could reveal important and potentially exploitable information for addressing HIV-1 infection in humans.
引用
收藏
页码:1579 / 1588
页数:10
相关论文
共 50 条
  • [1] Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif
    Bizhan Romani
    Susan Engelbrecht
    Richard H. Glashoff
    Archives of Virology, 2009, 154 : 1579 - 1588
  • [2] Suppression of APOBEC3-mediated restriction of HIV-1 by Vif
    Feng, Yuqing
    Baig, Tayyba T.
    Love, Robin P.
    Chelico, Linda
    FRONTIERS IN MICROBIOLOGY, 2014, 5
  • [3] HIV-1 Vif, APOBEC, and Intrinsic Immunity
    Ritu Goila-Gaur
    Klaus Strebel
    Retrovirology, 5
  • [4] Pharmacologic inhibition of the HIV-1 vif: apobec axis
    Stevenson, Mario
    Rana, Tariq
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 : 60 - 60
  • [5] Distinct Determinants in HIV-1 Vif and Human APOBEC3 Proteins Are Required for the Suppression of Diverse Host Anti-Viral Proteins
    Zhang, Wenyan
    Chen, Gongying
    Niewiadomska, Anna Maria
    Xu, Rongzhen
    Yu, Xiao-Fang
    PLOS ONE, 2008, 3 (12):
  • [6] Identification of HIV-1 Vif Regions Required for CBF-β Interaction and APOBEC3 Suppression
    Wang, Hong
    Liu, Bin
    Liu, Xin
    Li, Zhaolong
    Yu, Xiao-Fang
    Zhang, Wenyan
    PLOS ONE, 2014, 9 (05):
  • [7] HIV-1 Vif: HIV's weapon against the cellular defense factor APOBEC3G
    Kremer, M
    Schnierle, BS
    CURRENT HIV RESEARCH, 2005, 3 (04) : 339 - 344
  • [8] Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G
    Kouno, Takahide
    Shibata, Satoshi
    Shigematsu, Megumi
    Hyun, Jaekyung
    Kim, Tae Gyun
    Matsuo, Hiroshi
    Wolf, Matthias
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [9] Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G
    Takahide Kouno
    Satoshi Shibata
    Megumi Shigematsu
    Jaekyung Hyun
    Tae Gyun Kim
    Hiroshi Matsuo
    Matthias Wolf
    Nature Communications, 14
  • [10] APOBEC3F Determinants of HIV-1 Vif Sensitivity
    Land, Allison M.
    Shaban, Nadine M.
    Evans, Leah
    Hultquist, Judd F.
    Albin, John S.
    Harris, Reuben S.
    JOURNAL OF VIROLOGY, 2014, 88 (21) : 12923 - 12927